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Methods: From September 1989 to September 1994 we operated on a 
consecutive group of 256 patients with three-vessel disease in whom we used 
the right gastroepiploic artery together with both internal thoracic arteries. 
Vein grafts were not used in these patients. This population consisted of 233 
men and 23 women whose ages ranged from 31 to 77 years (mean age 57.8 
years). Results: Hospital morbidity and mortality were not directly related 
to the use of the gastroepiploic artery. Patency of the anastomoses in a 
subgroup of 56 patients (22%) a mean of 16 months after the operation was 
98% for the left internal thoracic artery, 96% for the right internal thoracic 
artery, and 88% for the gastroepiploic artery. Five-year actuarial survival 
(including in-hospital deaths) was 95.9% and was related only to age. From 
discharge until the end of follow-up, two patients had a myocardial 
infarction, six patients underwent a reintervention procedure, and 18 
patients had a return of angina pectoris. Conclusion: We conclude that the 
concomitant use of the gastroepiploic artery with the both internal thoracic 
arteries has low morbidity and mortality in patients with three-vessel 
disease operated on by experienced surgeons. At this moment, we have no 
reason to believe graft patency will deteriorate in the future. On the basis 
of these results, the knowledge that arteries are to be preferred over veins 
for coronary bypass grafting, and the absence of a leg incision, we believe 
this operative technique is superior to the use of venous grafts. (J Thorac 
Cardiovasc Surg 1996;112:935-42) 
T he use of the internal thoracic artery (ITA) graft for myocardial revascularization is superior to 
that of saphenous vein grafts because of higher 
patency rates and a lower mortality and morbid- 
ity. 1-4 Several authors recently showed that the use 
of both the left and right ITAs further decreases 
recurrence of angina and reoperations. 5-8 Still, ve- 
nous grafts continue to be used in the majority of 
patients having coronary bypass operations, mainly 
because of a shortage of arterial material and the 
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inability to reach the inferior surface of the heart 
with ITAs. 9' 10 In recent years, the gastroepiploic 
artery (GEA) has been a workable alternative to the 
saphenous vein graft, with short-term patency and 
clinical outcome similar to those of ITA grafts. 11-17 
We report on a series of 256 consecutive patients 
with three-vessel disease having coronary bypass 
operations with the use of arterial grafts exclusively; 
both the right and the left ITAs and the GEA were 
used, and venous grafts were not used. The aims of 
this study were to describe operative results, as well 
as midterm angiographic and clinical outcomes, of 
this homogeneous group and to identify risk factors 
that influenced these results. 
Patients and methods 
Patient population. Between September 1989 and Sep- 
tember 1994, 3720 patients were operated on for coronary 
artery disease in our institution. Revascularization f all 
three vessels was performed in 1495 patients. From this 
group of patients, venous grafts exclusively were used in 
104 patients (7%). A single ITA in conjunction with 
venous grafts was used in 1135 patients (76%) and the 
935 
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GEA in combination with one or two ITAs was used in 
256 patients (17%). The study population consisted of 
these 256 consecutive patients with three-vessel disease in 
whom the GEA was used in combination with both ITA 
grafts but no venous grafts. The main reason that only 
arterial grafts were used was that three of the eight 
surgeons who performed 244 of the 256 operations pre- 
ferred this approach. Other indications also played a role, 
such as the lack of other graft material and young age of 
some of the patients. In the study period, these three 
surgeons used this approach in 48%, 36%, and 13% of 
their patients in whom three vessels were bypassed. The 
main contraindications to this form of revascularization 
were technical problems uch as previous major opera- 
tions in this area or extreme obesity. It was not performed 
in a few patients with a short life expectancy. In 4% of the 
patients in whom we planned to do all-arterial three- 
vessel revascularization, the GEA appeared to be too 
small for use as a pedicled graft. In half of these patients, 
the GEA was used as a free graft, and in the other half the 
surgeon decided not the use the GEA as a graft. 
Elective angiography was performed in the 56 patients. 
In 25% of these patients, angiography was performed 
because of the return of symptoms. The other 75% of the 
patients were willing to undergo this procedure after 
giving written informed consent. 
All data were updated at the end of 1994 and were 
gathered by interview and examination by the patient's 
own cardiologist. 
Technique of the operation. The standard median ster- 
notomy was extended 5 cm caudally, after which the right 
ITA and then the left ITA were harvested. The pedicles 
were wrapped in a sponge soaked in papaverine solution. 
The pleural cavity was intentionally left closed. The 
peritoneal cavity was opened and the GEA was palpated 
gently to asses its caliber. The GEA was dissected with the 
use of two surgical clips (Hemoclip, medium, Pilling 
Weck, Research Triangle Park, N.C.) on each side branch 
to the stomach and omentum. The branches were divided 
by electrocoagulation. The GEA was dissected leftward 
two thirds of the distance along the great curvature of the 
stomach and proximal to the pylorus. After systemic 
heparinization, the distal part of the GEA graft was 
divided and 0.5 ml of a solution of papaverine (0.1 mg/ml) 
was gently injected into the distal part of the graft or was 
injected into the fatty tissue of the pedicle. The GEA was 
always routed anterior to the pylorus and the left lobe of 
the liver to the pericardial cavity. An incision in the 
diaphragm was made anterior to the inferior vena cava. 
The coronary anastomoses were made with running 8-0 
polypropylene sutures. The pedicle was fixed to the epi- 
cardium by means of two or three sutures (6-0 polypro- 
pylene) to avoid kinking of the graft at the anastomosis. 
The peritoneum was closed with a running resorbable 
suture without a drain. 
The right ITA was tunneled under the mediastinal fat, 
directly over the superior vena cava by incision of the 
pericardium, and was routed through the transverse sinus 
to reach the circumflex coronary artery. To reach the left 
anterior descending coronary artery the right ITA was 
also tunneled under the fatty tissue to avoid fixation to the 
sternum and was routed over the aorta. The left ITA was 
also routed under the mediastinal fat, deep along the 
parietal left pleura to either the left anterior descending 
or the circumflex coronary artery. Postoperative anticoag- 
ulation treatment consisted of acetyl salicylic acid 100 mg 
daily. 
Technique of angiography. Elective follow-up angiog- 
raphy was performed with the Judkins technique through 
the femoral approach. Standard Judkins 7F left and right 
coronary catheters, as well as pigtail catheters, were used 
for the native coronary artery injections and the left 
ventricular angiogram. ITA catheters were used for selec- 
tive angiography of the left and right ITA grafts. A special 
technique was developed for angiography of the GEA 
graft. The celiac trunk was cannulated by means of a 
lateral projection with a 7F special GEA catheter of our 
own design (built to specification by Cordis Europe NV, 
Roden, The Netherlands). Using the posteroanterior 
view, we advanced a soft, steerable 0.035-inch guide wire 
(Terumo Corporation, Tokyo, Japan) into the common 
hepatic artery or subselectively into the gastroduodenal 
artery. The contrast catheters were advanced over these 
guide wires into the gastroduodenal rtery or even into 
the origin of the GEA. This technique allowed for selec- 
tive hand injections of contrast medium and for excellent 
visualization of the GEA graft and its anastomoses, aswell 
as the native coronary artery distal to this anastomosis 
with multiple projections. All angiograms were recorded 
on movie film at 12.5 to 25 frames per second and were 
reviewed by two independent observers. 
End points. 1. Progression of atherosclerosis (graft 
stenosis) on cardiac catheterization was defined as any 
visible stenosis anywhere in the graft(s), including the sites 
of anastomoses. A patent graft was defined as a nonste- 
notic graft. 
2. In-hospital complications were defined as any unto- 
ward postoperative medical event that occurred during 
hospitalization. Atrial fibrillation was analyzed separately 
from other in-hospital complications. 
3. In-hospital and follow-up data were gathered on 
death, myocardial infarction, reintervention (percutane- 
ous transvenous coronary angioplasty or coronary artery 
bypass grafting), or the return of angina pectoris. 
Statistical analysis. The possible influence of the fol- 
lowing factors on clinical outcome of our study population 
was analyzed: age; sex; history of angioplasty, bypass 
grafting, myocardial infarction, diabetes mellitus, hyper- 
tension, hypercholesterolemia, cholecystectomy, or lapa- 
rotomy; body mass index; preoperative angina pectoris 
(New York Heart Association class); duration of opera- 
tion; number of distal anastomoses; surgeon; use of free 
grafts; and location of anastomosis of the GEA. 
Univariate and multivariate analysis of factors predicting 
graft progression, postoperative complications, and atrial 
fibrillation. The X 2 test was used for calculations of asso- 
ciations in contingency tables. When the sample was not 
large and the expected values were less than 5, we used 
Fisher's exact test. For differences between means, the t 
test was used. When variances where unequal, the Mann- 
Whitney U test was used. Factors that reached a signifi- 
cance level of less than 0.1 or any other clinically impor- 
tant factor such as age and sex were included for 
multivariate logistic regression analysis. The final model 
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Table I. Preoperative patient characteristics 
No. Percent of 256 
NYHA 
Class II-III 173 67 
class IV 83 33 
Myocardial infarction 140 54 
More than one infarction 20 7.8 
Hypercholesterolemia 133 52 
Diabetes 13 5.0 
PTCA 26 10 
Reoperation 28 11 
Prior laparotomy (upper) 9 3.6 
NYHA, New York Heart Association; PTCA, percutaneous transluminal 
coronary angioplasty. 
Table II. Number of anastomoses of bypass arteries 
to coronary arteries 
G EA L I TA R[ TA 
LAD 1 160 88 
Diagonal 1 98 13 
CX 6 139 166 
RCA 41 - -  3 
RPD 198 - -  - -  
RPL 17 - -  - -  
Total 264 397 270 
GEA, Gastroepiploic artery; LITA, left internal thoracic artery; R/MA, 
right internal thoracic artery; LAD, left anterior descending coronary 
artery; CX,, circumflex coronary artery; RCA, right coronary artery; RPD, 
right posterior descending; RPL, right posterolateral. 
consisted only of factors that had reached a significance 
level of less than 0.1 in previous models. 
Univariate and multivariate survival analysis of death, 
myocardial infarction, reintervention, or the return of angina 
pectoris. To identify prognostic factors that might have 
"explained" outcome differences in our study population, 
we estimated survival curves by the method escribed by 
Kaplan and Meier. 1~ Differences in survival times between 
groups were calculated by the log-rank and the Wilcoxon 
tests. All variables with a significance l vel ofp < 0.1 in at 
least one of these univariate tests and all other clinically 
important variables, uch as age and sex, were included for 
multivariate analysis as proposed by Cox. 19 The final 
model consisted only of variables that had reached a 
significance l vel of less than 0.1 in the previous model. 
We checked the assumption of proportional hazards for 
each predictor variable by estimating the plots of the 
logarithm of the cumulative hazard against he logarithm 
of time. 
Results 
Patients. The study group consisted of 233 men 
and 23 (10%) women with a median age of 57.8 
years (range 31 to 77 years). Preoperative patient 
characteristics are shown in Table I. These patients 
were a subgroup from 1495 patients who underwent 
three-vessel revascularization. This group consisted 
of 1128 men and 367 women (24%) with a mean age 
65.5 years (range 31 to 87 years). 
Grafts and anastomoses. In the group of 256 
patients operated on with the use of three arterial 
grafts, a total of 931 anastomoses (667 ITA anasto- 
moses, 264 GEA anastomoses) were performed; 
there were 768 arterial grafts and no vein grafts 
(Table II). The mean number of anastomoses per 
patient was 3.64. The mean number of anastomoses 
of left ITA grafts was 1.5, right ITA grafts 1.1, and 
GEA grafts 1.0. A sequential left ITA graft was used 
in 129 patients (50%) (117 with two distal anasto- 
moses, 12 with three distal anastomoses). A sequen- 
tial right ITA graft was used in 15 patients (6%) and 
a sequential GEA graft in eight patients (3.1%). A 
free ITA graft was used in seven patients and a free 
GEA graft was used in only three patients. 
In-hospital complications. Four patients (1.8%) 
died in the hospital. One patient died of brain 
infarctions, one patient of a myocardial infarction 
caused by embolization of atheromatous material 
from the aorta, one died of an anterior infarction 
after the left anterior descending branch was not 
found, and one died of cardiac failure. Two patients 
underwent reoperation a few hours after the first 
operation because of ischemia of the inferior aspect 
of the heart. A vein graft was placed next to the 
GEA anastomosis in one of the patients. Five 
postoperative angioplasty procedures were per- 
formed; one angioplasty of the right coronary artery, 
because the GEA was occluded, two angioplasties of
the GEA at its anastomosis, and two angioplasties of
the left anterior descending coronary artery. Medi- 
astinitis occurred in two patients. The sternum was 
secondarily closed after a period of open treatment, 
after 3 and 4 weeks. Mild gastrointestinal bleeding 
occurred twice and was treated medically. None of 
the patients had severe late abdominal symptoms at 
follow-up. Twenty-five patients (10%) used H 2 
blockers. In-hospital myocardial infarction occurred 
in six patients (2.4%) according to clinical symp- 
toms, electrocardiographic changes, and elevated 
levels of cardiac enzymes. Reoperations for persis- 
tent bleeding were necessary in 18 patients (7.8%). 
In two patients the bleeding was from the pedicle of 
the GEA graft. In nine patients, we needed an 
intraaortic balloon pump; in three of the nine 
patients the pump had already been inserted before 
the operation because of severe stenosis of the left 
main coronary artery. 
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Fig. 1. Five-year actuarial survival (including in-hospital death) for patients who received three arterial 
grafts. 
Table III. Results from multiple logistic regression for identifying risk factors for in-hospital complications, 
postoperative paroxysmal trial fibrillation, and graft occlusion on postoperative angiography 
Yes No Odds ratio (95% CI) p Value 
In-hospital complications 
Duration of operation (mean) 243 rain 213 min 
Atrial fibrillation 
Age (mean) 62.8 years 56.9 years 
Hypercholesterolemia 36% 59% 
Use of aprotinin 30% 14% 
Graft occlusion 
Duration of operation (mean) 273 min 223 min 
1.008 (1.002-1.013) 0.004 
1.073 (1.029-1.120) 0.001 
0.47 (0.22-0.97) 0.042 
2.29 (1.05-2.93) 0.049 
1.014 (1.001-1.026) (per min) 0.033 
Only risk factors with p < 0.05 are presented. Data are presented as odds ratios and 95% confidence intervals (CI). 
In summary, in-hospital complications occurred 
in 48 (19%) of the patients. Both univariate and 
multivariate analysis revealed that the in-hospital 
complications were individual surgeon-dependent 
(p = 0.002). After adjustment for this and other 
clinically important covariates in a multivariate lo- 
gistic regression model, only the duration of the 
operation appeared to be an independent predictor 
of the occurrence of in-hospital complications (Ta- 
ble III). There was a gradual increase in in-hospital 
complications with increased uration of the oper- 
ation, where the odds-ratio per minute was 1.008 
(95% confidence interval [CI] 1.002 to 1.013, p = 
0.004). This means that (for example) every 30 
minutes, the risk for in-hospital complications in- 
creased 1.0083o = 1.27 times. 
Atrial fibrillation. Paroxysmal postoperative 
atrial fibrillation occurred in 43 patients (16.8%) 
and was in most cases successfully controlled by 
medication. Again, there appeared to be a correla- 
tion between atrial fibrillation and the surgeon who 
performed the operation. After adjustment for this 
and other covariates, age appeared to be a strong 
independent risk factor for postoperative atrial fi- 
brillation (see Table III). The mean age of patients 
with postoperative atrial fibrillation was 62.8 years, 
compared with 56.9 years in the group without atrial 
fibrillation. The multivariate odds ratio per year was 
1.073 (95% CI 1.029 to 1.120, p = 0.001). Other 
independent risk factors were the use of aprotinin 
(odds ratio 2.3, 95% CI 1.0 to 5.2, p < 0.05) and a 
decreased risk for patients with a history of hyper- 
cholesterolemia (odds ratio 0.5, 95% CI 0.2 to 1.0, 
p = 0.04). 
Mortality and morbidity during follow-up. No 
patient was lost to follow-up. Mean postoperative 
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Table IV. Results from multivariate Cox proportional hazards analysis for identifying risk factors for death, 
myocardial infarction, and the return of angina pectoris 
Risk factor Hazard ratio (95% CI) p Value 
Death Age 1.52 (1.18-1.95) 0.001 
Myocardial infarction Redo operation 6.3 (1.5-26.5) 0.01 
Angina pectoris History of PTCA 4.6 (1.4-!5.2) 0.01 
Female sex 4.6 (1.3-16.3) 0.02 
Only risk factors with p < 0.05 are presented. Data are presented as hazard ratios and 95% confidence intervals (CI). PTCA, Percutaneous transluminal 
coronary angioplasty. 
Table V. Three-year actuarial survival for myocardial infarction, reintervention, or the return of angina 
pectoris, for a group of patients older than 65 and 70 years, respectively, compared with patients younger than 
65 and 70 years, respectively: p values are calculated by the log-rank test 
Survival for: < 65 yr (%) >-65 yr (%) p Value < 70 yr >- 70 yr p Value 
Myocardial Infarction 96 95 0.18 96 95 0.30 
Reintervention 95 97 0.59 95 100 0.23 
Angina pectoris 90 88 0.65 89 90 0.91 
follow-up was 25 _ 15 months (up to 58 months). 
During follow-up, six patients died, four of whom 
are described in the section In-hospital complica- 
tions. The other two patients died 25 and 38 months 
after the operation, one of rupture of an abdominal 
aortic aneurysm and the other of a noncardiovascu- 
lar cause. Five-year actuarial survival (including 
in-hospital death) for this group of patients who 
received three arterial grafts was 95.9% (Fig. 1). 
From discharge to the end of follow-up, two patients 
had a myocardial infarction, six patients underwent 
a reintervention procedure, and 18 patients had a 
return of angina pectoris. Three-year actuarial free- 
dom from any of these events (including in-hospital 
events) was 85%. 
Multivariate Cox proportional hazards analysis 
revealed that age was an independent risk factor for 
death (hazard ratio per year 1.5, 95% CI 1.2 to 1.9, 
p = 0.001). The only independent risk factor for 
myocardial infarction was reoperation (hazard ratio 
6.3, 95% CI 1.5 to 26.5,p = 0.01), and we found no 
independent risk factor for reintervention. Female 
patients were significantly more at risk for the return 
of angina pectoris (hazard ratio 4.6, 95% CI 1.3 to 
16.1, p = 0.02), and the return of angina pectoris 
was also significantly associated with a previous 
angioplasty procedure (hazard ratio 4.6, 95% CI 1.4 
to 15.2,p = 0.01) (Table IV). 
Older patients did not have increased risks for 
myocardial infarction, reintervention, or the return 
of angina pectoris during follow-up. Actuarial sur- 
vival analysis yielded comparable results between 
Table VI. Patency rate per anastomosis according 
to grafted coronary artery 
LAD CX RCA 
LITA 53/54 33/33 
RITA 25/25 30/32 2/2 
GEA 3/5 49/54 
LITA, Left internal thoracic artery; R/MA, right internal thoracic artery. 
GEA, gastroepiploic artery; LAD, left anterior descending artery; CX, 
circumflex artery; RCA, right coronary artery. 
patients older and younger than 65 years, as well as 
between patients older and younger than 70 years 
(Table V). As can be expected, older patients were 
at greater isk of dying during follow-up. Five-years 
survival for patients older than 65 years was 89%, 
compared with 98% for patients younger than 65 
years (p = 0.04). 
Graft patency. Angiography was performed in 56 
patients after a mean of 16 months (up to 61 
months). In 25% of these patients, angiography was 
performed because of the return of symptoms and in 
the other group for study reasons only. 
In 49 patients (88%), the GEA with its anastomo- 
ses were still patent, whereas a patent left ITA was 
present in 55 patients (98%) and a patent right ITA 
in 54 patients (96%) (Table VI). There was no 
difference in patency whether the left or right ITA 
was anastomosed to the left anterior descending or 
the circumflex artery. Even the anastomoses be- 
tween the GEA and right coronary artery or its 
branches had a patency rate of 90%. However, GEA 
anastomoses to the circumflex artery appeared to be 
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patent at angiographic follow-up in only three of the 
five patients (60%) in whom the GEA was used. 
In multiple logistic regression analysis, only dura- 
tion of operation remained a significant predictor 
for total progression of disease at follow-up angiog- 
raphy (see Table III). We found no specific predic- 
tive factors for progression in the GEA and its 
anastomoses. 
Discussion 
Several authors have reported that long-term 
survival after coronary bypass operations with the 
use of one ITA graft to the left anterior descending 
coronary artery is superior to the use of autologous 
saphenous vein grafts, particularly in younger pa- 
tients.3, 20-22 Moreover, the use of both the left and 
right ITAs further improved short-term and mid- 
term morbidity and mortality, although long-term 
outcome in patients receiving two ITAs remains 
unknown. 5-7 In our institution, an increasing num- 
ber of second operations are performed on patients 
who were previously operated on with a combina- 
tion of one ITA and one vein graft, in whom the vein 
grafts closed but the ITA is patent. On the basis of 
these findings, it seemed desirable to use arterial 
grafts exclusively in patients with three-vessel dis- 
ease, However, complete arterial revascularization 
for three-vessel disease usually cannot be achieved 
with ITAs alone, because too many anastomoses are 
needed for only two grafts. Another shortcoming of 
both left and right ITAs is their anatomic position, 
which often prevents revascularization f the poste- 
rior surface of the heart. Finally, a leg incision for 
harvesting the saphenous vein graft is usually an 
important source of discomfort o patients. These 
findings together emphasized the need to identify 
additional arteries uitable for myocardial revascu- 
larization. 
The right GEA was found to be a promising 
alternative bypass conduit for the saphenous 
vein. H-13 Large series of patients reported on by 
Suma and associates ~4 and by us ~6 showed that the 
in situ GEA has a suitable diameter for bypass 
grafting and is long enough to reach coronary 
arteries on the inferior ventricular wall; anastomo- 
ses to the left anterior descending and circumflex 
arteries were also possible. These studies also 
showed good short-term and midterm patency and a 
low mortality and morbidity, However, these patient 
groups also consisted of patients with one- or two- 
vessel disease. 
Like Jegaden and colleagues, 17who had a large 
series, we also report on a consecutive group of 
patients in whom the GEA and both ITAs were 
routinely used for complete arterial revasculariza- 
tion of three-vessel disease. However, patients with 
this all-arterial revascularization were younger than 
the total group of 1495 patients with three-vessel 
revascularization and consisted of more male pa- 
tients. Obviously, this technique was preferable in 
younger patients with a longer life expectancy. On 
the other hand, older age was not a risk factor for 
postoperative morbidity and increased graft failure, 
as demonstrated with coronary angiography. 
The use of the GEA in our study group did not 
lead to a significant increase in perioperative mor- 
tality. Overall, four patients (1.7%) died in the 
hospital, and mortality was not related to an inferior 
wall infarction, the area revascularized by the GEA. 
At late follow-up neither of the two deaths was 
cardiac related. In addition, use of the GEA did not 
lead to an increase in perioperative morbidity for 
coronary bypass operations. Reoperations for per- 
sistent bleeding were performed in 18 patients. This 
prevalence of bleeding complications was probably 
due to the use of antithrombotic therapy until the 
day before the operation and to the cautious use of 
aprotinin. Only three of these 18 reoperations for 
persistent bleeding were due to bleeding of the 
gastroepiploic pedicle, located in the pericardial and 
abdominal cavities. Gastric morbidity was extremely 
limited. In this group we observed no gastric com- 
plications after harvesting the GEA. Within this 
group of patients, the duration of the operation 
appeared to be an independent predictor for the 
occurrence of postoperative in-hospital complica- 
tions and for graft occlusion during follow-up. Dis- 
section of both ITAs and of the GEA is done by the 
same surgeon, who does the entire operation from 
skin to skin. However, we agree with Lytle and 
coworkers 13 that the use of the GEA increases the 
difficulty and complexity of the operation. The op- 
eration should be performed by experienced sur- 
geons. 
A subgroup of patients underwent follow-up an- 
giography at a mean of 16 months after the opera- 
tion. It should be noted, however, that 25% of these 
patients underwent coronary angiography because 
of the return of symptoms. Therefore this was a 
biased population, in which an increased occlusion 
rate could be expected. The GEA was widely patent 
in 88% of the patients, however, despite an occlu- 
sion rate of 40% when the GEA was used as a graft 
for the circumflex coronary artery. The latter finding 
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could be explained by the need for a longer graft to 
the circumflex artery and thus a diminished iame- 
ter of the GEA. Therefore the diameters of the 
distal anastomoses to the circumflex artery were 
probably much smaller than when the GEA was 
used for branches of the right coronary artery. 
Despite this increased occlusion rate, the use of the 
GEA for the circumflex artery in the entire study 
population did not appear to be a risk factor for 
mortality or morbidity during follow-up. 
The most common postoperative complication 
was atrial fibrillation. Independent risk factors for 
atrial fibrillation were age, no history of hypercho- 
lesterolemia, and the use of aprotinin. Age is a 
widely known risk factor for atrial fibrillation, but we 
could not explain the other risk factors. The risk for 
myocardial infarction during midterm follow-up was 
greater after reoperations. Independent predictive 
factors for the return of angina pectoris were a 
previous coronary angioplasty procedure before the 
operation and female sex. The latter probably re- 
sults from the fact that the grafts and grafted 
arteries are smaller in women than in men. 23 Age 
appeared to be no risk factor for in-hospital compli- 
cations and morbidity during midterm follow-up 
(see Table V). Overall, in-hospital Complications, 
prevalence of myocardial infarction, reintervention, 
and the return of angina pectoris did not seem to be 
different between patients with all-arterial revascu- 
!arization and those with a standard bypass opera- 
tion in which one ITA graft and vein grafts were 
used. 
Comparison has to be made between the saphe- 
nous vein and the GEA as revascularization con- 
duits. Unlike the saphenous vein graft, the GEA was 
found to have charaCteristics omparable with those 
of the ITAs. O'Neil and associates 24concluded from 
their study on endothelial function of the GEA that 
the artery possessed the necessary properties to be a 
potentially successful arterial bypass graft. We 25 
previously reported similar relaxation of GEA and 
ITA to methacholine and sodium nitrite, suggesting 
comparable ndothelial function in the two arteries. 
This implies that the protective role of the endothe- 
lium, which probably contributes to the high patency 
rate of ITAs, is also applicable to GEAs. 
Our choice for routine use of the GEA rather 
than other arterial grafts, such as the radial artery or 
inferior epigastric artery, is fueled by the ease of 
harvesting, the advantage of an in situ graft, and its 
flow and size. There is also no need for an extra skin 
incision. 
Encouraged by these results, we now use the 
GEA graft as the first adjunct o both ITAs even in 
elderly patients. Previous gastric resection is an 
absolute contraindication to the use of the GEA as 
a graft, whereas severe obesity, abdominal aortic 
operations, and previous cholecystectomy are minor 
considerations. In patients with insulin-dependent 
diabetes the use of two ITA grafts was associated 
with a higher risk of sternal infections. 26 However, 
we performed these operations in 11 patients with 
insulin-dependent diabetes and observed no prob- 
lems with sternal wound healing. 
In conclusion, our patients with three-vessel cor- 
onary artery disease who were revascularized with 
the GEA and the left and right ITAs had excellent 
short-term and midterm results. Mortality and mor- 
bidity were low even in elderly patients. At this time, 
we have no indications of progressive deterioration 
of graft patency. On the basis of these results, 
together with the knowledge that arteries are to be 
preferred over veins for coronary bypass grafting 
and the absence of a leg incision, we believe this 
operative technique to be superior to the use of 
venous grafts. 
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